DJ Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Boston Scientific Corp. $(BSX)$ slid 1.87% to $50.47 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.69% to 7,691.76 and Dow Jones Industrial Average falling 0.22% to 53,343.40.
This was the stock's second consecutive day of losses.
Boston Scientific Corp. closed 53.91% below its 52-week high of $109.50, which the company achieved on September 9th.
The stock underperformed when compared to some of its competitors Tuesday, as Abbott Laboratories $(ABT)$ rose 2.09% to $112.68, Medtronic PLC $(MDT)$ rose 1.64% to $92.09, and Stryker Corp. $(SYK)$ fell 0.09% to $331.37.
Trading volume (11.7 M) remained 8.1 million below its 50-day average volume of 19.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.